OPERON S.A.

Camino del Plano 19
Cuarte de Huerva-Zaragoza,  50410

Spain
https://www.operondx.com

• Booth: 3153

We provide the following high quality products: - LF Rapid Tests: wide range of analytes. - Molecular Diagnostics : Hybridization on strip & Real Time products. - Raw Materials: MAbs & rAgs - Contract Manufacturing Services. All our know how is available as a service.

 Press Releases

• Respiratory Bacterial Panel Strip (Jun 14, 2024)
  • Respiratory Bacterial Panel Strip kit is a test based on the reverse blot technique that allows the detection and identification of several bacteria associated with respiratory tract infections in respiratory DNA samples.
  • Respiratory Bacterial Panel Strip kit allows the detection of the following bacteria in respiratory tract samples (nasopharyngeal and bronchoalveolar swab/ washes/ aspirates, sputum, etc.): S. pneumoniae, B. pertussis, B. parapertussis, B. holmesii, Legionella spp (also differentiating L. pneumophila, L. micdadei, L. longbeachae, L. bozemanae), M. pneumoniae, C. pneumoniae, H. influenzae (differentiating type b from non-type b) and M. catarrhalis. 

• Real Respiratory Bacterial Panel 2 (Jun 14, 2024)
  • The Bordetella genus is formed of 8 species, of which only the following are human pathogens: B. pertussis, B. parapertussis and B. holmesii. The disease caused by B. pertussis and B. parapertussis is known as whooping cough. It is a major risk today, with 50 million cases per year and 300,000 deaths (mostly among infants and neonates). Therefore, a reliable diagnosis is required to initiate appropriate treatment and contact prophylaxis.
  • Diagnosis of Bordetellae based on culture or serological techniques has special requirements, is sometimes very time-consuming or does not provide good sensitivity data. For this reason, molecular techniques based on the detection of insertion sequences (IS) can be an interesting alternative to increase the sensitivity in the detection of these pathogens.
  • The Real Respiratory Bacterial Panel 2 test provides a simple, inexpensive and reliable way to detect all infections caused by bordetellas B. pertussis, B. parapertussis and B. holmesii.

• CD1WB and CD2WB: test for the detection of anti-gliadin and anti human tiss (Jun 14, 2024)

  • Celiac disease is a human enteropathy caused by a permanent intolerance to gluten and more specifically to its protein fraction called gliadin. The ingestion of this protein induces, in genetically predisposed individuals, a severe lesion of the intestinal mucosa characterised histologically by crypt hyperplasia with total or subtotal atrophy of the intestinal villi.

  • Due to the lack of a common symptomatology to facilitate diagnosis, as well as the high number of asymptomatic cases with intestinal deterioration, 85% of people with celiac disease are unaware of their gluten intolerance. This could lead to multiple and quite serious diseases, so the importance of early detection is vital to avoid major problems and allow the intestine to regenerate.

  • The Simple CD1WB test allows the detection in blood, plasma or serum of antibodies (IgA/IgG/IgM) directed against human tissue transglutaminase, the main autoantigen recognised by anti-endomysial antibodies.
  • The Simple CD2WB test allows the detection of IgA anti-gliadin and anti-human tissue transglutaminase antibodies in blood and/or serum. The latter is especially indicated for paediatric patients under 16 years of age, and is available in authorised pharmacies.

• Qualitative detection of Streptococcus pyogenes (Group A Streptococcus) (Jun 14, 2024)
  • One-step immunochromatographic test for the qualitative detection of Streptococcus pyogenes (Group A Streptococcus) from respiratory samples.
  • Group A Streptococcus (S. pyogenes) is one of the major causes of respiratory infections in the human upper respiratory tract, being the most significant pathogen causing pharyngitis. In the paediatric population, in fact, it is estimated to be responsible for 30% of pharyngitis. Symptoms can become severe if the patient does not receive treatment, so early identification of this pathogen allowing early initiation of antibiotic treatment is of vital importance to prevent the development of these complications.
  • Conventional methods for Group A Streptococcus testing and identification require 24-28 hours of incubation of cultures from throat swabs and subsequent confirmation of beta-haemolytic colonies as Group A Streptococcus.
  • The Simple/Stick Strep A test is a method using specific antibodies against a specific Group A Streptococcus antigen. The test detects both viable and non-viable micro-organisms directly from throat swabs or culture colonies within 10 minutes (or less in the case of highly positive samples).